USPTO trademark

BREKFLUVA

Under examinationUSPTOWord markClass 5

"BREKFLUVA" is a word mark owned by GlaxoSmithKline Biologicals SA, filed at the USPTO on September 16, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View GlaxoSmithKline Biologicals SA portfolioGet this data via the API
Official USPTO record
BREKFLUVA trademark as filed
As filed with the USPTO
Status
Under examination
Since October 11, 2026
Filed
September 16, 2026
Registered
Not yet
Priority date
September 10, 2026
Application no.
50111431
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns BREKFLUVA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GlaxoSmithKline Biologicals SA

Rixensart, Belgium

3,098 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services BREKFLUVA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Assigned to examiner
  5. Application filing receipt mailed
  6. New application office supplied data entered
  7. New application entered
FAQ

About BREKFLUVA

Who owns the trademark "BREKFLUVA"?

The USPTO trademark "BREKFLUVA" (application 50111431) is owned by GlaxoSmithKline Biologicals SA.

What is the status of "BREKFLUVA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BREKFLUVA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0af7f-0599-716d-a0f4-1a8b70b277ae
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0af7f-0599-716d-a0f4-1a8b70b277ae",
  "object": "trademark",
  "mark_text": "BREKFLUVA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50111431",
  "filing_date": "2026-09-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GlaxoSmithKline Biologicals SA",
      "entity_id": "ent_019eb6fa-f71d-76cb-987c-9c96b2781170"
    }
  ]
}